PASQUINI, Silvia
PASQUINI, Silvia
Dipartimento di Scienze chimiche, farmaceutiche ed agrarie
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives
file con accesso da definire2022 Catarzi, D.; Varano, F.; Vigiani, E.; Calenda, S.; Melani, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Mennini, N.; Nerli, G.; Dal Ben, D.; Volpini, R.; Colotta, V.
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
2020 Vincenzi, F.; Pasquini, S.; Battistello, E.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?
file con accesso da definire2022 Merighi, Stefania; Nigro, Manuela; Travagli, Alessia; Pasquini, Silvia; Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Gessi, Stefania
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma
2021 Vincenzi, F.; Rotondo, J. C.; Pasquini, S.; Di Virgilio, F.; Varani, K.; Tognon, M.
Adenosine and inflammation: Here, there and everywhere
2021 Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K.
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields
file con accesso da definire2017 Varani, Katia; Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Setti, Stefania; Cadossi, Matteo; Borea, Pier Andrea; Cadossi, Ruggero
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
file con accesso da definire2022 Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F.
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes
2020 Pasquini, S.; Vincenzi, F.; Casetta, I.; Laudisi, M.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists
2019 Catarzi, D.; Varano, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Dal Ben, D.; Volpini, R.; Colotta, V.
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?
2021 Merighi, Stefania; Poloni, Tino Emanuele; Pelloni, Lucia; Pasquini, Silvia; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors
file con accesso da definire2023 Gianferrara, Teresa; Pavan, Matteo; Bassani, Davide; Vincenzi, Fabrizio; Pasquini, Silvia; Bolcato, Giovanni; Varani, Katia; Spalluto, Giampiero; Federico, Stephanie; Moro, Stefano
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists
file con accesso da definire2012 Pasquini, S; Mugnaini, C; Ligresti, A; Tafi, A; Brogi, S; Falciani, C; Pedani, V; Pesco, N; Guida, F; Luongo, L; Varani, Katia; Borea, Pa; Maione, S; Di Marzo, V; Corelli, F.
Development of novel pyridazinone-based adenosine receptor ligands
2018 Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Varani, Katia; Vincenzi, Fabrizio; Pasquini, Silvia; Dal Ben, Diego; Colotta, Vittoria
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
file con accesso da definire2023 Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists
2018 Varano, Flavia; Catarzi, Daniela; Falsini, Matteo; Vincenzi, Fabrizio; Pasquini, Silvia; Varani, Katia; Colotta, Vittoria
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity
2019 Betti, M.; Catarzi, D.; Varano, F.; Falsini, M.; Varani, K.; Vincenzi, F.; Pasquini, S.; Di Cesare Mannelli, L.; Ghelardini, C.; Lucarini, E.; Dal Ben, D.; Spinaci, A.; Bartolucci, G.; Menicatti, M.; Colotta, V.
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease
file con accesso da definire2022 Merighi, Stefania; Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Travagli, Alessia; Nigro, Manuela; Pasquini, Silvia; Suresh, R Rama; Kim, Sung Won; Volkow, Nora D; Jacobson, Kenneth A; Gessi, Stefania
Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists
2020 Varano, F.; Catarzi, D.; Vigiani, E.; Vincenzi, F.; Pasquini, S.; Varani, K.; Colotta, V.
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
file con accesso da definire2022 Papa, A.; Pasquini, S.; Contri, C.; Gemma, S.; Campiani, G.; Butini, S.; Varani, K.; Vincenzi, F.
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety
2016 Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Romagnoli, Romeo; Baraldi, Pier Giovanni; Borea, Pier Andrea; Varani, Katia
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives | 2022 | Catarzi, D.; Varano, F.; Vigiani, E.; Calenda, S.; Melani, F.; Varani, K.; Vincenzi, F.; Pasquini..., S.; Mennini, N.; Nerli, G.; Dal Ben, D.; Volpini, R.; Colotta, V. | file con accesso da definire |
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? | 2020 | Vincenzi, F.; Pasquini, S.; Battistello, E.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K. | |
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? | 2022 | Merighi, Stefania; Nigro, Manuela; Travagli, Alessia; Pasquini, Silvia; Borea, Pier Andrea; Varan...i, Katia; Vincenzi, Fabrizio; Gessi, Stefania | file con accesso da definire |
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma | 2021 | Vincenzi, F.; Rotondo, J. C.; Pasquini, S.; Di Virgilio, F.; Varani, K.; Tognon, M. | |
Adenosine and inflammation: Here, there and everywhere | 2021 | Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K. | |
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields | 2017 | Varani, Katia; Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, ...Stefania; Setti, Stefania; Cadossi, Matteo; Borea, Pier Andrea; Cadossi, Ruggero | file con accesso da definire |
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets | 2022 | Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F. | file con accesso da definire |
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes | 2020 | Pasquini, S.; Vincenzi, F.; Casetta, I.; Laudisi, M.; Merighi, S.; Gessi, S.; Borea, P. A.; Varan...i, K. | |
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists | 2019 | Catarzi, D.; Varano, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Dal Ben, D.; Volpini, R.; Colott...a, V. | |
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? | 2021 | Merighi, Stefania; Poloni, Tino Emanuele; Pelloni, Lucia; Pasquini, Silvia; Varani, Katia; Vincen...zi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania | |
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors | 2023 | Gianferrara, Teresa; Pavan, Matteo; Bassani, Davide; Vincenzi, Fabrizio; Pasquini, Silvia; Bolcat...o, Giovanni; Varani, Katia; Spalluto, Giampiero; Federico, Stephanie; Moro, Stefano | file con accesso da definire |
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists | 2012 | Pasquini, S; Mugnaini, C; Ligresti, A; Tafi, A; Brogi, S; Falciani, C; Pedani, V; Pesco, N; Guida..., F; Luongo, L; Varani, Katia; Borea, Pa; Maione, S; Di Marzo, V; Corelli, F. | file con accesso da definire |
Development of novel pyridazinone-based adenosine receptor ligands | 2018 | Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Varani, Katia; Vincenzi, Fabrizio; Pasquini, S...ilvia; Dal Ben, Diego; Colotta, Vittoria | |
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions | 2023 | Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; ...Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania | file con accesso da definire |
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists | 2018 | Varano, Flavia; Catarzi, Daniela; Falsini, Matteo; Vincenzi, Fabrizio; Pasquini, Silvia; Varani, ...Katia; Colotta, Vittoria | |
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity | 2019 | Betti, M.; Catarzi, D.; Varano, F.; Falsini, M.; Varani, K.; Vincenzi, F.; Pasquini, S.; Di Cesar...e Mannelli, L.; Ghelardini, C.; Lucarini, E.; Dal Ben, D.; Spinaci, A.; Bartolucci, G.; Menicatti, M.; Colotta, V. | |
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease | 2022 | Merighi, Stefania; Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Travagli, Alessia; Nigr...o, Manuela; Pasquini, Silvia; Suresh, R Rama; Kim, Sung Won; Volkow, Nora D; Jacobson, Kenneth A; Gessi, Stefania | file con accesso da definire |
Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists | 2020 | Varano, F.; Catarzi, D.; Vigiani, E.; Vincenzi, F.; Pasquini, S.; Varani, K.; Colotta, V. | |
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition | 2022 | Papa, A.; Pasquini, S.; Contri, C.; Gemma, S.; Campiani, G.; Butini, S.; Varani, K.; Vincenzi, F. | file con accesso da definire |
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety | 2016 | Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, Stefania; Romag...noli, Romeo; Baraldi, Pier Giovanni; Borea, Pier Andrea; Varani, Katia |